Science Survey Examines 10 Potential Vaccines Needing To Move Forward In Clinical Trials

Science: Unfilled Vials
“…Developed in university, government, or industry labs, [several experimental vaccines] have proven effective in animals and even been tested in small human trials. But because the diseases they target, like Ebola, are not seen as important threats in the developed world, they have not attracted the industry investment needed to prove efficacy in people. … With the help of a dozen vaccine experts, Science compiled its own list … [of experimental vaccines] that do not present obvious scientific hurdles, would fill a pressing public health need, and have attracted scant attention from the pharmaceutical industry…” (Cohen, 1/1).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.